List of Tables
Table 1. Global End Stage Renal Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Transplantation
Table 3. Key Players of Dialysis
Table 4. Global End Stage Renal Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global End Stage Renal Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global End Stage Renal Disease Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global End Stage Renal Disease Market Share by Region (2020-2025)
Table 8. Global End Stage Renal Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global End Stage Renal Disease Market Share by Region (2026-2031)
Table 10. End Stage Renal Disease Market Trends
Table 11. End Stage Renal Disease Market Drivers
Table 12. End Stage Renal Disease Market Challenges
Table 13. End Stage Renal Disease Market Restraints
Table 14. Global End Stage Renal Disease Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global End Stage Renal Disease Market Share by Players (2020-2025)
Table 16. Global Top End Stage Renal Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease as of 2024)
Table 17. Ranking of Global Top End Stage Renal Disease Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by End Stage Renal Disease Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of End Stage Renal Disease, Headquarters and Area Served
Table 20. Global Key Players of End Stage Renal Disease, Product and Application
Table 21. Global Key Players of End Stage Renal Disease, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global End Stage Renal Disease Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global End Stage Renal Disease Revenue Market Share by Type (2020-2025)
Table 25. Global End Stage Renal Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global End Stage Renal Disease Revenue Market Share by Type (2026-2031)
Table 27. Global End Stage Renal Disease Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global End Stage Renal Disease Revenue Market Share by Application (2020-2025)
Table 29. Global End Stage Renal Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global End Stage Renal Disease Revenue Market Share by Application (2026-2031)
Table 31. North America End Stage Renal Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America End Stage Renal Disease Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America End Stage Renal Disease Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe End Stage Renal Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe End Stage Renal Disease Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe End Stage Renal Disease Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific End Stage Renal Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific End Stage Renal Disease Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific End Stage Renal Disease Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America End Stage Renal Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America End Stage Renal Disease Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America End Stage Renal Disease Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa End Stage Renal Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa End Stage Renal Disease Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa End Stage Renal Disease Market Size by Country (2026-2031) & (US$ Million)
Table 46. Nipro Corporation Company Details
Table 47. Nipro Corporation Business Overview
Table 48. Nipro Corporation End Stage Renal Disease Product
Table 49. Nipro Corporation Revenue in End Stage Renal Disease Business (2020-2025) & (US$ Million)
Table 50. Nipro Corporation Recent Development
Table 51. Fresenius Medical Care Company Details
Table 52. Fresenius Medical Care Business Overview
Table 53. Fresenius Medical Care End Stage Renal Disease Product
Table 54. Fresenius Medical Care Revenue in End Stage Renal Disease Business (2020-2025) & (US$ Million)
Table 55. Fresenius Medical Care Recent Development
Table 56. Baxter International, Inc. Company Details
Table 57. Baxter International, Inc. Business Overview
Table 58. Baxter International, Inc. End Stage Renal Disease Product
Table 59. Baxter International, Inc. Revenue in End Stage Renal Disease Business (2020-2025) & (US$ Million)
Table 60. Baxter International, Inc. Recent Development
Table 61. Medtronic Plc Company Details
Table 62. Medtronic Plc Business Overview
Table 63. Medtronic Plc End Stage Renal Disease Product
Table 64. Medtronic Plc Revenue in End Stage Renal Disease Business (2020-2025) & (US$ Million)
Table 65. Medtronic Plc Recent Development
Table 66. B. Braun Melsungen AG Company Details
Table 67. B. Braun Melsungen AG Business Overview
Table 68. B. Braun Melsungen AG End Stage Renal Disease Product
Table 69. B. Braun Melsungen AG Revenue in End Stage Renal Disease Business (2020-2025) & (US$ Million)
Table 70. B. Braun Melsungen AG Recent Development
Table 71. BD Company Details
Table 72. BD Business Overview
Table 73. BD End Stage Renal Disease Product
Table 74. BD Revenue in End Stage Renal Disease Business (2020-2025) & (US$ Million)
Table 75. BD Recent Development
Table 76. Asahi Kasei Medical Co., Ltd. Company Details
Table 77. Asahi Kasei Medical Co., Ltd. Business Overview
Table 78. Asahi Kasei Medical Co., Ltd. End Stage Renal Disease Product
Table 79. Asahi Kasei Medical Co., Ltd. Revenue in End Stage Renal Disease Business (2020-2025) & (US$ Million)
Table 80. Asahi Kasei Medical Co., Ltd. Recent Development
Table 81. Cantel Medical Company Details
Table 82. Cantel Medical Business Overview
Table 83. Cantel Medical End Stage Renal Disease Product
Table 84. Cantel Medical Revenue in End Stage Renal Disease Business (2020-2025) & (US$ Million)
Table 85. Cantel Medical Recent Development
Table 86. Nikkiso Co., Ltd Company Details
Table 87. Nikkiso Co., Ltd Business Overview
Table 88. Nikkiso Co., Ltd End Stage Renal Disease Product
Table 89. Nikkiso Co., Ltd Revenue in End Stage Renal Disease Business (2020-2025) & (US$ Million)
Table 90. Nikkiso Co., Ltd Recent Development
Table 91. JMS Co. Ltd. Company Details
Table 92. JMS Co. Ltd. Business Overview
Table 93. JMS Co. Ltd. End Stage Renal Disease Product
Table 94. JMS Co. Ltd. Revenue in End Stage Renal Disease Business (2020-2025) & (US$ Million)
Table 95. JMS Co. Ltd. Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. End Stage Renal Disease Picture
Figure 2. Global End Stage Renal Disease Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global End Stage Renal Disease Market Share by Type: 2024 VS 2031
Figure 4. Transplantation Features
Figure 5. Dialysis Features
Figure 6. Global End Stage Renal Disease Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global End Stage Renal Disease Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. End Stage Renal Disease Report Years Considered
Figure 12. Global End Stage Renal Disease Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global End Stage Renal Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global End Stage Renal Disease Market Share by Region: 2024 VS 2031
Figure 15. Global End Stage Renal Disease Market Share by Players in 2024
Figure 16. Global Top End Stage Renal Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by End Stage Renal Disease Revenue in 2024
Figure 18. North America End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America End Stage Renal Disease Market Share by Country (2020-2031)
Figure 20. United States End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe End Stage Renal Disease Market Share by Country (2020-2031)
Figure 24. Germany End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific End Stage Renal Disease Market Share by Region (2020-2031)
Figure 32. China End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America End Stage Renal Disease Market Share by Country (2020-2031)
Figure 40. Mexico End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa End Stage Renal Disease Market Share by Country (2020-2031)
Figure 44. Turkey End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE End Stage Renal Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Nipro Corporation Revenue Growth Rate in End Stage Renal Disease Business (2020-2025)
Figure 48. Fresenius Medical Care Revenue Growth Rate in End Stage Renal Disease Business (2020-2025)
Figure 49. Baxter International, Inc. Revenue Growth Rate in End Stage Renal Disease Business (2020-2025)
Figure 50. Medtronic Plc Revenue Growth Rate in End Stage Renal Disease Business (2020-2025)
Figure 51. B. Braun Melsungen AG Revenue Growth Rate in End Stage Renal Disease Business (2020-2025)
Figure 52. BD Revenue Growth Rate in End Stage Renal Disease Business (2020-2025)
Figure 53. Asahi Kasei Medical Co., Ltd. Revenue Growth Rate in End Stage Renal Disease Business (2020-2025)
Figure 54. Cantel Medical Revenue Growth Rate in End Stage Renal Disease Business (2020-2025)
Figure 55. Nikkiso Co., Ltd Revenue Growth Rate in End Stage Renal Disease Business (2020-2025)
Figure 56. JMS Co. Ltd. Revenue Growth Rate in End Stage Renal Disease Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed